dihexa clinical trials human studies status Dihexa Capsules Suppliers, Manufacturers, Factory dihexa clinical trials humans Sublingual
Description
If possible, work under a laminar flow hood
The inhibition rate goes along with the increased dose of 1D228 and Tepotinib, the IC 50 of 1D228 were 4.3 nM or 1 nM respectively on MHCC97H or MKN45, which is lower than the reference compound Tepotinib which is 13 nM or 1.65 nM
However, long-term human safety trials are lacking, so usage should be approached with caution
J Pharmacol Sci 2008
Pharmaceutical-grade manufacturing with batch-level documentation available for qualified buyers
Linda H
